New study reveals patients’ changing needs during COVID-19
coronavirus, COVID-19, patient groups, patient organisations, Patients Association
0 Comment
patient organisations
Education as the solution to the rare disease ‘diagnostic odyssey’
patient groups, patient organisations, scleroderma
0 Comment
BMS launches digital Advocacy Exchange for patient groups affected by COVID-19
BMS, Bristol-Myers Squibb, coronavirus, COVID-19, Digital Health & COVID-19, Gryt Health, patient groups, patient organisations, Pharma’s Digital Response to COVID-19
0 Comment
Industry and patient groups collaborate on new guidance for interaction
comms, IAPO, IFPMA, patient groups, patient organisations
0 Comment
Why pharma isn’t collaborating with patient organisations as much as it should
Accenture, patient centricity, patient engagement, patient groups, patient organisations
0 Comment
Preliminary Attendee List Released for Orphan Drugs & Rare Diseases Conference
drug development, orphan drugs, patient centricity, patient organisations, Rare diseases
0 Comment
Attendees Released for Orphan Drugs & Rare Diseases
How challenges like Brexit & insufficient patients hinder Rare Diseases research
collaboration, Funding, orphan drugs, patient organisations, Rare diseases
0 Comment
Challenges facing Orphan Drugs & Rare Diseases Research